tiprankstipranks
LifeMD initiated with a Neutral at Mizuho
PremiumThe FlyLifeMD initiated with a Neutral at Mizuho
2M ago
ADA advises doctors, patients not to use compounded GLP-1s
Premium
The Fly
ADA advises doctors, patients not to use compounded GLP-1s
2M ago
Hims & Hers jumps as status report says patients unable to obtain branded GLP-1s
Premium
The Fly
Hims & Hers jumps as status report says patients unable to obtain branded GLP-1s
2M ago
LifeMD launches affiliated pharmacy to drive end-to-end patient care
PremiumThe FlyLifeMD launches affiliated pharmacy to drive end-to-end patient care
2M ago
LifeMD launches TestoRx, direct to consumer testosterone replacement therapy
Premium
The Fly
LifeMD launches TestoRx, direct to consumer testosterone replacement therapy
3M ago
BTIG says market demand for lower cost GLP1-s should benefit LifeMD, Him & Hers
Premium
The Fly
BTIG says market demand for lower cost GLP1-s should benefit LifeMD, Him & Hers
3M ago
LifeMD sees Q3 revenue $53M-$54M, consensus $53.27M
PremiumThe FlyLifeMD sees Q3 revenue $53M-$54M, consensus $53.27M
5M ago
LifeMD reports Q2 EPS 6c, consensus (12c)
Premium
The Fly
LifeMD reports Q2 EPS 6c, consensus (12c)
5M ago
LifeMD price target lowered to $10 from $12 at KeyBanc
Premium
The Fly
LifeMD price target lowered to $10 from $12 at KeyBanc
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100